Per Hellsund

Per Hellsund has held various leadership roles throughout their career. Per is currently the President & CEO of Cybrexa Therapeutics, a company focused on developing small molecule DNA repair inhibitors. Prior to this, they were the President & CEO of CyOmics, where they worked to develop and commercialize products in the Life Sciences and Diagnostics field. Per also served as President & CEO of CyVek, inc.jet, Inc., and Gunther International, where they held various executive positions.

Per Hellsund has obtained a Master of Science in Management from Rensselaer Polytechnic Institute. No further information is available regarding their education history, such as specific dates or other degrees.